Drug Trial Radar · NCT01658124
Haemorrhage Alleviation With Tranexamic Acid- Intestinal System
Last checked: Nov 19, 2026Latest source record: Apr 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12,009
Actual
Start
Jul 2013
Primary completion
Jul 19, 2019
Study completion Jul 19, 2019
Sponsor
- Lead sponsor
- London School of Hygiene and Tropical MedicineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Rawalpindi Medical College; University of Ibadan
- First posted
- Aug 6, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Severe bleeding in the digestive system is a common symptom of many diseases. Each year, about 50,000 people end up in British hospitals because of this problem and about 5,000 of them die. The most common cause of this bleeding is stomach ulcers. In sub-Saharan Africa, schistosomiasis (parasitic worms) is responsible for about 130,000 deaths from stomach bleeding each year. From previous research in other bleeding conditions such as surgery and trauma, we know that a drug called tranexamic acid can reduce bleeding and save lives. We now want to do the HALT-IT trial to see if giving tranexamic acid can save lives and if there are any complications in people with severe bleeding from the digestive system.
Conditions
- Gastrointestinal Bleeding
Interventions
Tranexamic AcidDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- The primary outcome is death from haemorrhageTime frame: within 5 days of randomisation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Over 50 countries Worldwide
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.